On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...